Apr 26, 2014 by Brendan MathewsRobert Half International Placed a Good QuarterThis sleepy stock continues to improve profitability and earnings per share, and its international segment seems to have turned the corner.
Apr 26, 2014 by Brendan Mathews and Jason MoserWhat's the Future of Coca-Cola?Two of the Fool's analysts discuss the future of Coca-Cola and whether the company is losing the younger generation to healthier options.
Apr 25, 2014 by Brendan Mathews and Jason Moser5 Stellar Long-Term Growth StocksThe Fool's top analysts discuss the best long-term growth stocks for a grandfather's investment into his grandchild's future.
Apr 25, 2014 by Brendan Mathews and Jason MoserHow to Price Companies With High P/E RatiosTwo of the Fool's analysts answer some common beginning investor questions.
Apr 25, 2014 by Brendan MathewsNucor Forges AheadNucor's operations improved in the first quarter, and its financial position is still strong, but its foreign competition remains a big problem.
Apr 25, 2014 by Brendan Mathews and Jason MoserIs This a Buying Opportunity for Kinder Morgan?Two of the Fool's analysts give their Foolish opinion on Kinder Morgan.
Apr 24, 2014 by Brendan MathewsInside Valeant Pharmaceuticals' Bid for AllerganHere’s why this pharmaceutical megamerger seems like a good deal for both companies.
Apr 22, 2014 by Brendan MathewsHere's Why Interactive Brokers Group, Inc. Crushes the Competition You may not have heard about Interactive Brokers, but it's crushing the competition.
Apr 21, 2014 by Brendan MathewsWhat's a Prime Member Worth to Amazon.com?Calculating the customer lifetime value of Amazon Prime members.
Apr 21, 2014 by Brendan MathewsChipotle's Recipe for SuccessThe four key ingredients for 12 times returns since 2006.
Apr 15, 2014 by Brendan MathewsAsk a Fool: What Do You Need to See to Not Worry About P/E Ratios?Sometimes a high P/E ratio is a big red flag to stay away from a stock, and other times the market ignores P/E altogether. How can investors tell the difference?
Apr 15, 2014 by Brendan MathewsAsk a Fool: GOOG vs. GOOGL SharesWhat's the story behind Google's new tickers? Is one class of shares better than the other?
Apr 15, 2014 by Brendan MathewsAsk a Fool: Are There Opportunities for Investors in Russian Stocks?After the recent volatility in Russian stocks due to the Crimean conflict, is there a value play to be made here in Russian stocks?
Apr 15, 2014 by Brendan MathewsIs This the Time to Buy Pharma Stocks?Is now the right time to get in on pharmaceutical stocks?
Apr 7, 2014 by Brendan MathewsDo Fools Trade Penny Stocks?Here's why we steer clear of penny stocks here at the Fool.
Apr 7, 2014 by Brendan MathewsOur Foolish Opinion of BitcoinCan Bitcoin be seen as an actual investment?
Apr 7, 2014 by Brendan Mathews5 Things to Look For in an InvestmentHere are five things for investors to look for before buying shares of any business.
Apr 7, 2014 by Brendan MathewsWhy Pharmaceutical Penny Stocks Just Aren't Worth the RiskWe've all heard internet anecdotes or stories from a friend of a friend who made a great deal of money investing in penny stocks. But in reality, the odds against the investor are stacked very high.
Mar 28, 2014 by Brendan MathewsWhy Accenture's Slow Growth Isn't as Bad as It SeemsSure, revenue growth was weak -- but in every other way, the company’s doing surprisingly well.
Mar 26, 2014 by Brendan MathewsWhat Happens to Shorted Shares in a Bankruptcy?What happens to shares sold short when a company goes bankrupt?
